For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Heron Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 35

EPO Patents = 9

Trademarks = 34

Forward Citations = 157

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Thomas B Ottoboni (32 out of 53 patents)

Lee Ann Lynn Girotti (14 out of 14 patents)

Han Han (14 out of 19 patents)

4. Lee Ann Lynn Schillinger (4 out of 4 patents)

5. Steven Y Ng (3 out of 21 patents)

6. Jorge Heller (3 out of 56 patents)

7. Hui-Rong Shen (2 out of 6 patents)

8. Joseph Niemann (2 out of 3 patents)

9. Hui Rong Shen (1 out of 4 patents)

10. Barry D Quart (19 patents)

11. Jorge Heller (0 patent)

12. Hui-Rung Shen (0 patent)

Core Competencies:

Polyorthoester

Aprotic Solvent

NK-1 Receptor Antagonist

Emulsion Formulations

Long-Acting Delivery Systems

Granisetron

Semi-Solid Delivery Vehicle

Pharmaceutical Compositions

35 patents: Sort by Forward Citations

1. 12318376 - Compositions of a polyorthoester and an aprotic solvent (2025-06-03),

2. 12290520 - Methods of use of emulsion formulations of aprepitant (2025-05-06),

3. 12115255 - Methods of use of emulsion formulations of an NK-1 receptor antagonist (2024-10-15),

4. 12115254 - Methods of use of emulsion formulations of an NK-1 receptor antagonist (2024-10-15),

5. 11878074 - Methods of use of emulsion formulations of an NK-1 receptor antagonist (2024-01-23),

6. 11844837 - Compositions of a polyorthoester and an organic acid excipient (2023-12-19),

7. 11744800 - Methods of use of emulsion formulations of an NK-1 receptor antagonist (2023-09-05),

8. 11413350 - Long-acting polymeric delivery systems (2022-08-16),

9. 11253504 - Compositions of a polyorthoester and an aprotic solvent (2022-02-22),

10. 11173118 - Emulsion formulations of an NK-1 receptor antagonist and uses thereof (2021-11-16),

11. 11083797 - Long-acting polymeric delivery systems (2021-08-10),

12. 11083730 - Long-acting polymeric delivery systems (2021-08-10),

13. 10980886 - Compositions of a polyorthoester and an organic acid excipient (2021-04-20),

14. 10953018 - Emulsion formulations of aprepitant (2021-03-23),

15. 10898575 - Long-acting polymeric delivery systems (2021-01-26),

Company Overview

Heron Therapeutics, Inc. is a biopharmaceutical company based in San Diego, California, focused on developing innovative therapies for patients with significant unmet medical needs. The company specializes in the development of novel drug formulations and delivery systems, particularly in the areas of pain management and cancer care. Heron's research emphasizes enhancing the efficacy and safety of existing treatments, aiming to improve patient outcomes through advanced therapeutic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

35 Patents

#179 in San Diego, CA

#2,314 in California

#9,778 in US

#19,220 in the World

San Diego, CA, United States of America

Heron Therapeutics, Inc.

Forward Citations = 157

9 inventors:

Thomas B Ottoboni (32 out of 53 patents)

Lee Ann Lynn Girotti (14 out of 14 patents)

Han Han (14 out of 19 patents)

4. Lee Ann Lynn Schillinger (4 out of 4 patents)

5. Steven Y Ng (3 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Heron Therapeutics, Inc.. Retrieved from https://idiyas.com/company/heron-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…